Ambu

Ambu provides resuscitation bags, airway management tools, and clinical evidence for healthcare professionals.

Ambu supplies first-responder and training products, such as manikins and disposable resuscitators.

The page describes Ambu’s cardiology solutions tailored to specific needs.

Learn about precise, safe and efficient single-use eeg and emg electrodes from Ambu, and explore other valuable resources for neurologists.

The AuraGain is Ambu’s 2nd generation laryngeal mask, satisfying 3 fundamental airway management needs by integrating gastric access and intubation capability in an anatomically curved single-use device that facilitates rapid establishment of a safe airway.

The Ambu AuraOnce provides the safety and convenience of a sterile, single-use product, yet is remarkably cost-effective in use.

The page summarizes scientific research on Ambu products, including randomized controlled trials, cost-analyses, and literature reviews.

Listen to a 20-minute on-demand webinar to learn about front-line evidence based on bronchoscopies performed on COVID-19 patients.

Download the complete logo package here (13.6 mb)

The Ambu image bank offers photos in low and high resolution for screen and print use.

The page introduces Ambu’s innovations in healthcare, trusted by clinicians in over 60 countries.

The Board of Directors includes a chair appointed until 2025, born in 1968, who holds positions at 3Shape A/S, VELUX A/S, and other companies.

Ambu’s Board of Directors oversees management, sets objectives and budgets, and ensures compliance with Danish law and company bylaws.

Ambu’s Board of Directors comprises nine members: six elected by shareholders and three by employees, following Danish law.

1.1 The Innovation Committee (the “Committee”) is a committee of the Board of Directors of Ambu A/S established in accordance with the Rules of Procedure of the Board of Directors.

Ambu aims to minimize its products’ environmental impact and reduce greenhouse gas emissions, energy use, and waste.

The page provides an overview of Ambu, including its focus areas, locations, history, and values.

Ambu has developed breakthrough healthcare solutions since 1937.

Ambu A/S Baltorpbakken 13 DK-2750 Ballerup

The page offers a form for questions or comments about Ambu, its products, or its website.

Ambu is a medical device company offering product, career, investor, and contact information for healthcare professionals.

Danish medical company Ambu acquires Foresight Imaging, a US-based endoscopy firm. The deal includes an upfront cash payment of $45 million, with additional milestone-based payments totaling up to $20 million. Foresight Imaging is known for developing Tims Medical products.

Sep 2026dealroom.coNews article

Ambu reports strong endoscopy product growth in Q3 2025/26, driven by demand in healthcare procedures. The company highlights expanding market share in reusable and single-use endoscopy tools. Management notes persistent margin pressures from supply chain costs and competitive pricing.

Aug 2026Investing.comNews article

Ambu A/S reports strong revenue growth in Q2 2026, driven by core medical device sales despite currency exchange (FX) challenges. The company highlights resilience in demand for its respiratory and anesthesia products across key markets. Management attributes performance to operational efficiency and strategic investments in emerging regions.

May 2026Investing.comNews article

Ambu receives FDA 510(k) clearance for its HD cystoscopy solution. The device follows earlier regulatory approval in Europe, where it earned a CE mark in October 2023. This clearance expands Ambu’s presence in the U.S. urology market.

Oct 2024urologytimes.comNews article